PARI’S APPROACH

... to developing new aerosol therapies is to optimize liquid drug formulations to Advanced Aerosol Delivery platforms such as the eFlow electronic nebulizer. We combine three important development aspects into each aerosol project in order to create an advanced therapy for the patient:

  • aerosol
  • pharma
  • assessment

With our proven track record of developing efficient aerosol delivery devices, optimizing pharmaceutical formulations, nearly 100 years of experience, and clinical trial success, PARI is an ideal development partner for new inhalation therapies.